ArticleFoods (Basel, Switzerland)2026
The Potential for Bioactive Peptide Production in a Fermented Dairy Beverage Based on Chickpea Water Extract Using Proteolytic Lactic Acid Bacteria.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A chickpea-based milk beverage containing both plant and animal proteins represents an excellent substrate for the production of biologically active peptides through fermentation. Fermentation by lactic acid bacteria (LAB) increases its nutritional value compared to the unfermented beverage while improving the digestibility and bioavailability of essential nutrients via proteolytic enzyme activity. This study investigated the production of bioactive peptides in fermented chickpea water extract using ten bacterial strains isolated from plant and animal sources. The proteolytic activity of each strain was quantified using the trinitrobenzene sulfonic acid (TNBS) method, and the presence of proteolytic genes was confirmed via agarose gel electrophoresis. Peptides released during fermentation were identified through two-dimensional electrophoresis, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), and tandem mass spectrometry. To predict the potential biological activities of the studied peptide sequences, a series of in silico analyses were performed using specialized bioinformatics tools. The identified peptides were predicted to exhibit antioxidant, antihypertensive, anticancer, antibacterial, antifungal, antituberculosis, and angiotensin-converting enzyme (ACE) inhibitory activities. Based on the results,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.